Insider · CIK 0002063082
Amy Parison
cfoofficer
Files at EDIT (Editas Medicine, Inc.). First filing Jun 4, 2025, latest Sep 4, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $7,036 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EDIT: Editas Medicine, Inc.
EDITOct 9, 2026 · close 2.90
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | Editas Medicine, Inc. | $1,376 453 shares | -3% | - | |
| 17Weak | Editas Medicine, Inc. | $957 474 shares | -3% | +108% from low-51% from high | |
| 17Weak | Editas Medicine, Inc. | $993 461 shares | -3% | +141% from low-43% from high | |
| 17Weak | Editas Medicine, Inc. | $1,189 458 shares | -3% | +155% from low-37% from high | |
| 10Weak | Editas Medicine, Inc. | $1,752 679 shares | -4% | +154% from low-37% from high | |
| 17Weak | Editas Medicine, Inc. | $769 446 shares | -2% | +86% from low-54% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | EDIT Editas Medicine, Inc. | SOpen-market sale Common Stock10b5-1 | -453 | $3.04 | $1,376 | 13,839 | 38 d ago |
| Mar 12, 2026 | EDIT Editas Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative10b5-1 | +292,856 | $0.00 | $0 | 292,856 | Mar 16, 2026 |
| Mar 3, 2026 | EDIT Editas Medicine, Inc. | SOpen-market sale Common Stock10b5-1 | -474 | $2.02 | $957 | 15,434 | Mar 4, 2026 |
| Dec 3, 2025 | EDIT Editas Medicine, Inc. | SOpen-market sale Common Stock10b5-1 | -461 | $2.15 | $993 | 15,908 | Dec 4, 2025 |
| Sep 3, 2025 | EDIT Editas Medicine, Inc. | SOpen-market sale Common Stock10b5-1 | -458 | $2.60 | $1,189 | 16,369 | Sep 4, 2025 |
| Aug 7, 2025 | EDIT Editas Medicine, Inc. | SOpen-market sale Common Stock10b5-1 | -679 | $2.58 | $1,752 | 16,827 | Aug 8, 2025 |
| Jun 3, 2025 | EDIT Editas Medicine, Inc. | SOpen-market sale Common Stock10b5-1 | -446 | $1.72 | $769 | 17,506 | Jun 4, 2025 |
| Apr 8, 2025 | EDIT Editas Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +34,672 | $0.00 | $0 | 34,672 | Apr 8, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.